Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
about
Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationMaking the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugsImproving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugsOptiMal-PK: an internet-based, user-friendly interface for the mathematical-based design of optimized anti-malarial treatment regimensOptimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Intrahost modeling of artemisinin resistance in Plasmodium falciparumDevelopment, evaluation, and application of an in silico model for antimalarial drug treatment and failure.Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug TreatmentQuantifying the pharmacology of antimalarial drug combination therapy.Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination.Pharmacological considerations in the design of anti-malarial drug combination therapies - is matching half-lives enough?Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials.Problems with continuous-time malaria models in describing gametocytogenesis.A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin
P2860
Q26830528-3EE4D854-50D5-4158-9B3D-609FDA3C047BQ27025529-47ACF15D-5E2D-4A70-8B97-24D674055C62Q28534701-03E59DC9-685A-492E-95A2-5FCCB3205889Q28831110-D35E43E6-A82B-4452-8331-9E1763AA18A8Q33678483-D7EFBE1B-A762-4523-A274-22BCB35B4D12Q34471842-1257EAF2-B8F3-4978-A341-FCF69EBD76EBQ35065737-AA17C6F6-96AD-483E-8DB4-C3C1D89B626FQ35105913-65475ABA-9E3E-4CEC-B836-41B35B777B07Q35827084-E1A82930-EA60-4911-8304-FA467F1FA9E2Q36539049-C35684D3-4CDE-49BE-82E9-7933D634B320Q36888028-40803E32-753B-4B24-8E88-66D3A03A73AEQ37283299-D08D5F9D-DF27-4E1A-89E0-AE9BE1A56559Q37509562-90A74D90-EC44-43D9-84DB-6894D05F07CDQ37685088-A3F409CD-08DE-422D-9F0E-8806D7B46466Q38225084-C9755757-85E2-4417-AE6B-0E53AD79D1E0Q44141909-468612FF-FCAC-4CD0-9405-083E10E685A6Q47100908-A88E929D-C192-4E23-A096-14A19C639E1BQ56363318-4B50376D-6B00-451D-BFED-290372D2FE2B
P2860
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@en
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@nl
type
label
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@en
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@nl
prefLabel
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@en
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@nl
P2093
P1433
P1476
Pharmacokinetic-pharmacodynamic modelling of the antimalarial activity of mefloquine.
@en
P2093
P304
P356
10.1017/S003118200100854X
P577
2001-10-01T00:00:00Z